Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and tocopherol for prevention of osteoradionecrosis after tooth extraction in irradiated head and neck cancer patients
RBR-6tnqpjmRecruiting
- Sponsor
- Sociedade Pernambucana de Combate ao Câncer
- Start
- Jun 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pentoxifylline and tocopherol in osteoradionecrosis (ORN) (2 arms), sponsored by Sociedade Pernambucana de Combate ao Câncer. Started Jun 2024; status: recruiting.
02
Drugs
pentoxifyllinetocopherol
03
Conditions
osteoradionecrosis (ORN)
Beyond the preview
Go deeper on RBR-6tnqpjm.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6tnqpjm.